1. Assessment of Erythroid and Granulocytic Hematopoietic Lineages in Patients with Non-Small-Cell Lung Carcinoma
   V. E. Goldberg et al, 2017, Bulletin of Experimental Biology and Medicine CrossRef
2. Meta-analysis of published efficacy and safety data for docetaxel in second-line treatment of patients with advanced non-small-cell lung cancer
   Mark Stroh et al, 2016, Cancer Chemotherapy and Pharmacology CrossRef
3. Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy
   Fatma Sen et al, 2016, Medicine CrossRef
4. Oral vinorelbine plus cisplatin followed by maintenance oral vinorelbine as first-line treatment for advanced non-small cell lung cancer
   Fadi S. Farhat et al, 2015, Cancer Chemotherapy and Pharmacology CrossRef
5. An open-label, single-arm phase II clinical study of docetaxel plus lobaplatin for Chinese patients with pulmonary and hepatic metastasis of nasopharyngeal carcinoma
   Shuai Zhang et al, 2016, Anti-Cancer Drugs CrossRef
6. Retrospective evaluation of non-small cell lung cancer patients in Kırıkkale
   Selim Yalçın et al, 2018, Ortadoğu Tıp Dergisi CrossRef